e-ISSN: Pending
Failed Experiment ReportOpen accessNeuroscience· cited by 11

Microglia-derived nanovesicles synchronize macroautophagy and chaperone-mediated autophagy for Alzheimer’s disease therapy

Min Li; Min Li; Shuang Chen; Rong Guo; Mingrui Yang; Mingrui Yang; Yingke Liu; Qiang Zhang · 2025 · Signal Transduction and Targeted Therapy

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Dysregulated autophagy is a hallmark of Alzheimer's disease (AD), yet the extent of impairment in macroautophagy and chaperone-mediated autophagy (CMA) remains unclear. Here, we show that both pathways are disrupted in AD model mice, preceding β-amyloid accumulation and driving disease progression. However, therapeutic autophagy modulation is severely restricted by the blood-brain barrier (BBB). To overcome this, we developed Microglia-Liposome Fusion Extrusion (MiLi-FE), a method to engineer microglia-derived nanovesicles (AR@ENV) for the codelivery of AR7 (a CMA inducer) and rapamycin (a mac

Abstract by Min Li; Min Li; Shuang Chen; Rong Guo; Mingrui Yang; Mingrui Yang; Yingke Liu; Qiang Zhang, Signal Transduction and Targeted Therapy (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41392-025-02453-y